Elisa Scarselli

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Genome Wide Identification

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer immunology research

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Irene Garzia, Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, Simona Allocca, Giuseppina Romano, Laura Conti, Carmen Caiazza, Concetta Ambrosino, Valeria Poli, Elisa Scarselli, Anna Morena D'Alise
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine. Cancer immunology research 12 (4) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Irene Garzia, Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, Simona Allocca, Giuseppina Romano, Laura Conti, Carmen Caiazza, Concetta Ambrosino, Valeria Poli, Elisa Scarselli, Anna Morena D'Alise
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine. Cancer immunology research 12 (4) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Irene Garzia, Linda Nocchi, Lidia Avalle, Fulvia Troise, Guido Leoni, Laura Seclì, Laura Antonucci, Gabriella Cotugno, Simona Allocca, Giuseppina Romano, Laura Conti, Carmen Caiazza, Concetta Ambrosino, Valeria Poli, Elisa Scarselli, Anna Morena D'Alise
Tumor burden dictates the neoantigen features required to generate an effective cancer vaccine. Cancer immunology research (2024)
Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Veronica Venafra, Sven Gogov, Alessia Capone, Sarah Runswick, Juan Martín-Liberal, Emiliano Calvo, Victor Moreno, Stefan N Symeonides, Elisa Scarselli, Oliver Bechter
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Anna Morena D'Alise, Nadia Brasu, Carlo De Intinis, Guido Leoni, Valentina Russo, Francesca Langone, Denis Baev, Elisa Micarelli, Luca Petiti, Simone Picelli, Marwan G Fakih, Dung T Le, Michael James Overman, Anthony Frank Shields, Katrina S Pedersen, Manish A Shah, Sarbajit Mukherjee, Thea Faivre, Patricia Delaite, Elisa Scarselli, Luigia Pace
Adenoviral-based vaccine promotes neoantigen-specific CD8 + T cell stemness and tumor rejection. Science translational medicine 14 (657) (2022)